PMID: 2103644Aug 1, 1990Paper

Seroprevalence and risk factors for hepatitis B virus infection by AgHBs and anti-HBs markers in prisoners and prime blood donors

Revista de saúde pública
C M MartelliF Zicker

Abstract

Two cross-sectional surveys on hepatitis B virus (HBV) infection were carried out among 1,033 volunteer first-time blood donors in five blood banks (3 private, 2 public) and among 201 prisoners in the Penitentiary Center of Industrial Activity, in Goiania, Central Brazil, between June 1988 and February 1989. Those surveys were part of a major study designed to estimate seroprevalence of HBsAg and anti-HBsAg markers by ELISA test, and to study risk factors associated with seropositivity. The presence of any serum marker was considered as previous exposure to HBV. A standard questionnaire was applied to both populations to evaluate previous blood transfusion, number of sexual partners, homo/bisexual activity, history of sexually transmitted diseases, drug abusers, use of parenteral medicine, acupuncture, tattooing and VDRL seropositivity. Seroprevalence varied from 12.8% to 26.4% in blood donors and prisoners, respectively, (p less than 0.05) and increased with age (X2 trend=14.0 p less than 0.05%). Prisoners had higher percentages of all risk factors investigated than blood donors, with the exception of number of sexual partners. Among all risk factors studied, age, imprisonment and tattooing were statistically associated with s...Continue Reading

References

Jun 1, 1978·Journal of Clinical Pathology·A VollerD E Bidwell
Jul 14, 1979·Lancet·A E LimentaniJ K Lamborn
Apr 1, 1978·The Journal of Infectious Diseases·J P KoplanK R Berquist
Oct 1, 1975·Annals of Internal Medicine·W SzmunessG H Block
Feb 1, 1986·Infection Control : IC·R A Garibaldi
Jul 1, 1986·American Journal of Public Health·S LohiyaS Caires
Jan 1, 1988·Contributions to Nephrology·Q Maggiore, C Catalano
Jul 1, 1988·American Journal of Epidemiology·F ScheutzH J Alter
Jul 15, 1988·Annals of Internal Medicine·S C Hadler
Sep 1, 1988·American Journal of Epidemiology·T J van DitzhuijsenS H Yap
Jan 1, 1987·American Journal of Epidemiology·M J AlterJ E Maynard
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·J C FonsecaJ P Simonetti
Jun 1, 1988·Pediatric Clinics of North America·M S Edwards
Jul 1, 1987·Revista Do Instituto De Medicina Tropical De São Paulo·A R AbuzwaidaH G Schatzmayr
Apr 1, 1987·Memórias do Instituto Oswaldo Cruz·I F CamargoC F Yoshida
Nov 1, 1986·Revista Do Instituto De Medicina Tropical De São Paulo·L C da SilvaA Sáez-Alquézar
Nov 1, 1986·Revista Do Instituto De Medicina Tropical De São Paulo·L G LyraL Silva
Mar 1, 1986·International Journal of Epidemiology·C L GohA Kamarudin
Jul 1, 1985·The Journal of Infectious Diseases·M D DeckerW Schaffner
Jul 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J WareT Parker
Sep 1, 1984·The Journal of Infectious Diseases·M D DeckerW Schaffner
Nov 1, 1983·American Journal of Epidemiology·P PasquiniE Guzzanti
Jan 1, 1981·Annual Review of Medicine·J H Hoofnagle
Jan 1, 1982·American Journal of Epidemiology·J L Dienstag, D M Ryan
Jul 1, 1982·The Journal of Infectious Diseases·M T SchreederG Reynolds

❮ Previous
Next ❯

Citations

Jul 1, 1994·Revista Da Sociedade Brasileira De Medicina Tropical·M S de AzevedoA J Barbosa
Jul 22, 1999·Revista de saúde pública·J V FernandesA M Ferreira
Nov 19, 2010·Revista Da Sociedade Brasileira De Medicina Tropical·Alcione Cavalheiro Faro StiefAna Rita Coimbra Motta-Castro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.